An Oklahoma judge has ruled that he, not a jury, will decide the state’s case against several drug manufacturers for their alleged role in the nation’s deadly opioid crisis.
The attorney general’s office says Cleveland County District Judge Thad Balkman made the decision at an April 11 hearing that a jury won’t hear the case. At least one of the defendants, Johnson & Johnson, had sought a jury trial.
Attorney general spokesman Alex Gerszewski says Balkman also decided not to move the trial to a larger courtroom at the University of Oklahoma. The trial is scheduled to begin May 28.
Oklahoma settled with Purdue Pharma for $270 million in March in the first such agreement following a wave of nearly 2,000 lawsuits against the company that had threatened to push it into bankruptcy.
At the April 11 hearing, Balkman denied a request by Teva Pharmaceuticals to remove several of its subsidiaries and affiliates from the lawsuit.
Related:
- Purdue to Settle Oklahoma’s Opioids Lawsuit Weeks Before Trial to Open
- Oklahoma High Court Rejects Immediate Delay of Opioid Trial, Sets Hearing Date
- Oklahoma Judge Denies Purdue Pharma Bid to Delay Landmark Opioid Trial
- Judge Sends Oklahoma’s Lawsuit Against Opioid Makers Back to State Court
Topics Legislation Oklahoma
Was this article valuable?
Here are more articles you may enjoy.
PE-Backed Insurance Broker Hub International Files Confidentially for US IPO
Virginia’s New Gun Laws Challenged by Some Local Prosecutors and Lawsuits
What Happens to Property Pricing in ’27, Insurance, Reinsurance Execs Ask
Need Wind Mitigation? New Florida Insurer Wants to Help With That 

